Author

Ke Zu

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

OpenAlex ID: A5136746795

Real-world treatment patterns and outcomes for patients with extensive-stage small-cell lung cancer treated in US community oncology practices

2026 · Himani Aggarwal, Ke Zu, et al. · Frontiers in Oncology · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: